Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity
- 1 March 1998
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 1 (1) , 21-28
- https://doi.org/10.1016/s1368-7646(98)80211-2
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Human immunodeficiency virus type 1 protease inhibitorsArchives of internal medicine (1960), 1997
- Comparative Enzymatic Study of HIV-1 Reverse Transcriptase Resistant to 2‘,3‘-Dideoxynucleotide Analogs Using the Single-Nucleotide Incorporation AssayBiochemistry, 1997
- Zidovudine Resistance Reverse Transcriptase Mutations during Didanosine MonotherapyThe Journal of Infectious Diseases, 1996
- Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in PlasmaScience, 1996
- Lamivudine or Stavudine in Two- and Three-Drug Combinations against Human Immunodeficiency Virus Type 1 Replication In VitroThe Journal of Infectious Diseases, 1996
- Role of Methionine 184 of Human Immunodeficiency Virus Type-1 Reverse Transcriptase in the Polymerase Function and Fidelity of DNA SynthesisBiochemistry, 1996
- Differential phosphorylation of azidothymidine, dideoxycytidine, and dideoxyinosine in resting and activated peripheral blood mononuclear cells.Journal of Clinical Investigation, 1993
- Mechanism of DNA Strand Transfer Reactions Catalyzed by HIV-1 Reverse TranscriptaseScience, 1992
- HIV-1 entry into quiescent primary lymphocytes: Molecular analysis reveals a labile, latent viral structureCell, 1990
- Isolation of drug-resistant variants of HIV-1 from patients on long-term zidovudine therapyAIDS, 1989